|Articles|March 1, 2019
- BioPharm International-03-01-2019
- Volume 32
- Issue 3
BioPharm International, March 2019 Issue (PDF)
Click the title above to open the BioPharm International March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Successfully Moving Regulated Data to the Cloudover 6 years ago
Strategic Ventures Reflect Dynamic Growth in Chinaover 6 years ago
CMOs Leading the Way on Single-Use Systems Adoptionover 6 years ago
Cell and Gene Therapies Gain Streamlined FDA Oversightover 6 years ago
Considering Alternative Dosage Forms in Biologicsover 6 years ago
Test Methods and Quality Control for Prefilled Syringesover 6 years ago
Is Simplification Aiding Data Integrity Compliance?over 6 years ago
Caught in a ConundrumNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
5
